Shanghai Bao Pharmaceuticals Co Ltd Sustainability Reports
The company is a biotechnology enterprise focused on utilizing synthetic biology technology to develop next-generation recombinant protein therapeutics and antibody drugs. Its primary areas of operation include subcutaneous drug delivery, antibody-mediated autoimmune disease treatments, and assisted reproduction therapeutics.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01YVC5WT6
1 reports from 2025 to 2025